M. Nicholson

1.2k total citations
10 papers, 873 citations indexed

About

M. Nicholson is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, M. Nicholson has authored 10 papers receiving a total of 873 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pulmonary and Respiratory Medicine, 4 papers in Oncology and 3 papers in Surgery. Recurrent topics in M. Nicholson's work include Lung Cancer Treatments and Mutations (3 papers), Lung Cancer Research Studies (2 papers) and Cancer therapeutics and mechanisms (1 paper). M. Nicholson is often cited by papers focused on Lung Cancer Treatments and Mutations (3 papers), Lung Cancer Research Studies (2 papers) and Cancer therapeutics and mechanisms (1 paper). M. Nicholson collaborates with scholars based in United Kingdom, United States and Austria. M. Nicholson's co-authors include John C. Gallagher, J.E. Aaron, Josdalyne Anderson, B. E. C. Nordin, E. Longton, J Carmichael, RJ Stephens, M B McIllmurray, H Anderson and Robert Milroy and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and British Journal of Cancer.

In The Last Decade

M. Nicholson

9 papers receiving 805 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Nicholson United Kingdom 7 456 400 171 157 154 10 873
Uyen Duong United States 18 95 0.2× 111 0.3× 88 0.5× 203 1.3× 28 0.2× 18 1.1k
Hideki Ishida Japan 18 259 0.6× 471 1.2× 76 0.4× 393 2.5× 10 0.1× 120 1.1k
Laura Rocci Italy 13 809 1.8× 223 0.6× 41 0.2× 76 0.5× 291 1.9× 17 1.0k
Suporn Chuncharunee Thailand 20 103 0.2× 195 0.5× 73 0.4× 104 0.7× 17 0.1× 97 1.5k
Steven Andrèsen United States 16 347 0.8× 99 0.2× 205 1.2× 46 0.3× 9 0.1× 48 915
Dong-Wook Kim South Korea 18 139 0.3× 73 0.2× 58 0.3× 133 0.8× 40 0.3× 84 1.3k
Eivor Hernes Norway 14 320 0.7× 379 0.9× 114 0.7× 145 0.9× 37 0.2× 30 815
Akihiro Tsuchimoto Japan 12 107 0.2× 87 0.2× 103 0.6× 120 0.8× 11 0.1× 76 574
H. Schouten Curacao 15 170 0.4× 55 0.1× 124 0.7× 21 0.1× 19 0.1× 36 753
M. Schlichting Germany 9 847 1.9× 374 0.9× 604 3.5× 216 1.4× 296 1.9× 22 1.3k

Countries citing papers authored by M. Nicholson

Since Specialization
Citations

This map shows the geographic impact of M. Nicholson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Nicholson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Nicholson more than expected).

Fields of papers citing papers by M. Nicholson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Nicholson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Nicholson. The network helps show where M. Nicholson may publish in the future.

Co-authorship network of co-authors of M. Nicholson

This figure shows the co-authorship network connecting the top 25 collaborators of M. Nicholson. A scholar is included among the top collaborators of M. Nicholson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Nicholson. M. Nicholson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
2.
Meerbeeck, Jan P. van, M. Nicholson, David Gilligan, et al.. (2008). Adjuvant or neoadjuvant chemotherapy in early-stage non-small cell lung cancer (NSCLC): How would staging affect the patients (pts) treated?. Journal of Clinical Oncology. 26(15_suppl). 7509–7509. 1 indexed citations
3.
Rosell, Rafael, U. Gatzemeier, Daniel Betticher, et al.. (2002). Phase III randomised trial comparing paclitaxel/carboplatin with paclitaxel/cisplatin in patients with advanced non-small-cell lung cancer: a cooperative multinational trial. Annals of Oncology. 13(10). 1539–1549. 219 indexed citations
4.
Anderson, H, Penelope Hopwood, RJ Stephens, et al.. (2000). Gemcitabine plus best supportive care (BSC) vs BSC in inoperable non-small cell lung cancer – a randomized trial with quality of life as the primary outcome. British Journal of Cancer. 83(4). 447–453. 251 indexed citations
5.
Nicholson, M. & Carolyn M. Willis. (1999). The inuence of patch test size and design on the distribution of erythema induced by sodium lauryl sulfate. Contact Dermatitis. 41(5). 264–267. 8 indexed citations
6.
Ellis, Peter, Kenneth J. O’Byrne, D. Papamichael, et al.. (1996). Therapeutic monitoring of continuous infusion etoposide in small-cell lung cancer.. Journal of Clinical Oncology. 14(6). 1903–1912. 26 indexed citations
8.
McKeage, Mark J., et al.. (1993). Cisplatin, dacarbazine and tamoxifen for refractory advanced malignant melanoma. Melanoma Research. 3(1). 35–35. 1 indexed citations
9.
Cardella, Carl J., et al.. (1982). SUCCESSFUL RENAL TRANSPLANTATION IN PATIENTS WITH T-CELL REACTIVITY TO DONOR. The Lancet. 320(8310). 1240–1243. 75 indexed citations
10.
Aaron, J.E., John C. Gallagher, E. Longton, et al.. (1974). FREQUENCY OF OSTEOMALACIA AND OSTEOPOROSIS IN FRACTURES OF THE PROXIMAL FEMUR. The Lancet. 303(7851). 229–233. 224 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026